Overview

Title

Expressing support for the designation of the week of May 5, 2024, through May 11, 2024, as Tardive Dyskinesia Awareness Week.

ELI5 AI

H. RES. 1200 wants to make a special week in May 2024 to help people learn about Tardive Dyskinesia, a health problem that makes it hard to control some movements. This resolution encourages everyone to know more about it and how to help people who have it.

Summary AI

H. RES. 1200 is a resolution expressing support for designating the week of May 5, 2024, through May 11, 2024, as "Tardive Dyskinesia Awareness Week." Tardive dyskinesia (TD) is an involuntary movement disorder often caused by long-term use of medications for mental health and gastrointestinal disorders. The resolution emphasizes the importance of raising awareness about TD, encouraging regular monitoring and screening for the condition, and promoting knowledge of TD symptoms and available treatments within the public and medical community.

Published

2024-05-06
Congress: 118
Session: 2
Chamber: HOUSE
Status: Introduced in House
Date: 2024-05-06
Package ID: BILLS-118hres1200ih

Bill Statistics

Size

Sections:
1
Words:
171
Pages:
2
Sentences:
7

Language

Nouns: 53
Verbs: 9
Adjectives: 4
Adverbs: 1
Numbers: 13
Entities: 21

Complexity

Average Token Length:
3.98
Average Sentence Length:
24.43
Token Entropy:
4.05
Readability (ARI):
12.52

AnalysisAI

The resolution, H. RES. 1200, aims to designate the week of May 5, 2024, through May 11, 2024, as "Tardive Dyskinesia Awareness Week." This resolution has been introduced in the House of Representatives by Mr. Peters, alongside Mr. Bilirakis, Mr. Mullin, and Mr. Bean of Florida. The resolution is currently referred to the Committee on Energy and Commerce.

General Summary of the Bill

The core purpose of this resolution is to express support for increasing awareness of Tardive Dyskinesia (TD), a serious and often underdiagnosed movement disorder. TD often affects individuals who undergo long-term treatment with medications such as antipsychotics and antiemetics, which are frequently prescribed to those with mental or gastrointestinal disorders. The resolution underlines the importance of public awareness and regular health monitoring to improve the detection and management of this condition.

Summary of Significant Issues

Several important points are highlighted in the resolution. Firstly, it notes that TD affects approximately 600,000 individuals in the United States, with a significant portion yet to be diagnosed. This underdiagnosis underscores the need for greater public and medical community awareness. Secondly, the resolution stresses the importance of monitoring patients who are on dopamine receptor blocking agents and advocates for regular screening as recommended by health authorities. Importantly, this resolution does not entail any specific spending or direct appropriation, which makes legislative oversight on cost implications minimal.

Impact on the Public

The designation of a dedicated awareness week for Tardive Dyskinesia can serve as a valuable educational tool for the broad public. It raises crucial awareness among potential patients and their families, encouraging them to seek timely medical evaluation and advice. Public awareness can also lead to increased demand for healthcare providers to diligently monitor for TD symptoms, which can improve early intervention and treatment outcomes, thereby enhancing the quality of life for those affected.

Impact on Specific Stakeholders

For patients undergoing treatment for mental and gastrointestinal disorders, this resolution is potentially positive. By drawing attention to TD, it propels more proactive health care practices and potentially spurs advancements in treatment options. Healthcare providers, including psychiatrists and general practitioners, are encouraged to adopt regular screening practices, improving early identification rates. Additionally, pharmaceutical and health industries might see an increased impetus for developing more refined treatment options with fewer side effects.

In summary, H. RES. 1200 provides a structured approach to raise awareness of Tardive Dyskinesia, which can lead to improved health outcomes through education and early intervention. The resolution is straightforward, without complex legal intricacies, making its objectives accessible to the general audience, thus fostering a wider base of understanding and support for the cause.

Issues

  • The resolution does not specify any spending, removing concerns about potential wasteful spending. This is stated in the section where it mentions that the text does not specify any spending, making it difficult to identify potential wasteful spending.

  • The resolution appears to maintain neutrality without favoring any particular organization or individual, as mentioned in the section highlighting that the text appears neutral.

  • The language is clear and straightforward without ambiguity, which is essential for ensuring the public and stakeholders understand the message and actions being encouraged, as noted in the section stating the language is clear and straightforward.

  • The resolution is a simple expression of support and does not involve complex legal terms or jargon, reducing potential legal interpretations or misunderstandings, as indicated in the section about the absence of complex legal terms or jargon.

Sections

Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.

Read Opens in new tab

Summary AI

The House of Representatives supports the creation of "Tardive Dyskinesia Awareness Week" and encourages people in the United States to learn more about the condition.